Raymond James Reiterates “Outperform” Rating for Knight Therapeutics (TSE:GUD) Mayfield Recorder
Knight Therapeutics (TSE:GUD)’s stock had its “outperform” rating reaffirmed by research analysts at Raymond James in a note issued to investors on Thursday, …